Analysis of anti-cancer chemicals and pharmaceutical formulations

Ended Awarded Last action

Contract number
HHSN261201700013I
Awardee
Awarding agency
Task orders
1 $638 obligated

Award facts

Opportunity
  • NO2CM7700416 Solicitation number
Combined order value
$638 Current and potential, with all options
Last date to order 100% complete
IDV ceiling <1% used
$5,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00003 $0
Other Administrative Action P00002 · Analysis of anti-cancer chemicals and pharmaceutical formulations. POP: 08/01/2017 to 07/31/2022. $0
Other Administrative Action P00001 $0
Original award $0

Quick answers

Who was awarded contract HHSN261201700013I?

HHSN261201700013I was awarded to Research Triangle Institute by National Cancer Institute (National Institutes of Health) on July 31, 2017.

How much is contract HHSN261201700013I worth?

Orders under HHSN261201700013I have obligated $638. HHSN261201700013I's own ceiling is $5,000,000.

How many orders have been placed under contract HHSN261201700013I?

1 order has been placed under HHSN261201700013I, the latest on August 1, 2017.

Who can order from contract HHSN261201700013I?

HHSN261201700013I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN261201700013I part of a contract vehicle?

Yes. HHSN261201700013I is part of NIH Analysis of Anti-Cancer Chemicals 2017-2022.

Was contract HHSN261201700013I competed?

The extent of competition for HHSN261201700013I was full and open competition. The government received 4 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV